Human immunodeficiency virus-associated plasmablastic lymphoma

Cancer, 04/20/2012

The prognosis of Plasmablastic lymphoma (PBL) in HIV–infected individuals remains poor in the highly active antiretroviral therapy era. Intensive chemotherapy regimens do not seem to increase survival in patients with HIV–associated PBL.

Print Article Summary